Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
We are an AI driven drug discovery and development company. We analyze high-information content measurements directly from patients to discover and develop novel drug targets. We focus on inflammation - a process that drives many different diseases - ranging from Alzheimer’s to Heart Disease to Diabetes. Powerful treatments to control inflammation remains a major unmet medical need. Our approach has already led us to discoveries that we are building into drugs that will improve patient outcomes across multiple disease areas.